FDA 483 - PCCI, Inc. - December 02, 2021

An FDA inspection of PCCI, Inc. in Alexandria, VA, identified three significant observations related to their quality system. The firm failed to adequately establish records for acceptable suppliers, follow procedures for management review, and adhere to procedures for quality audits. These findings indicate deficiencies in the firm's quality management practices.